Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2000, p. 997-1003, Vol. 44, No. 4
Departamento de Resistencia
Bacteriana1 and Departamento de
Bioquímica de Patógenos,2
Instituto Nacional de Salud Pública, Centro de
Investigaciones Sobre Enfermedades Infecciosas, Cuernavaca, Morelos,
México
Received 29 April 1999/Returned for modification 20 December
1999/Accepted 14 January 2000
Escherichia coli R170, isolated from the urine of an
infected patient, was resistant to expanded-spectrum cephalosporins, aztreonam, ciprofloxacin, and ofloxacin but was susceptible to amikacin, cefotetan, and imipenem. This particular strain
contained three different plasmids that encoded two
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
TLA-1: a New Plasmid-Mediated Extended-Spectrum
-Lactamase from Escherichia coli

-lactamases with
pIs of 7.0 and 9.0. Resistance to cefotaxime, ceftazidime,
aztreonam, trimethoprim, and sulfamethoxazole was transferred by
conjugation from E. coli R170 to E. coli J53-2.
The transferred plasmid, RZA92, which encoded a single
-lactamase,
was 150 kb in length. The cefotaxime resistance gene that encodes the
TLA-1
-lactamase (pI 9.0) was cloned from the transconjugant by
transformation to E. coli DH5
. Sequencing of the
blaTLA-1 gene revealed an open reading
frame of 906 bp, which corresponded to 301 amino acid residues,
including motifs common to class A
-lactamases: 70SXXK,
130SDN, and 234KTG. The amino acid sequence of
TLA-1 shared 50% identity with the CME-1 chromosomal class A
-lactamase from Chryseobacterium (Flavobacterium) meningosepticum; 48.8%
identity with the VEB-1 class A
-lactamase from E. coli;
40 to 42% identity with CblA of Bacteroides uniformis,
PER-1 of Pseudomonas aeruginosa, and PER-2 of
Salmonella typhimurium; and 39% identity with CepA of Bacteroides fragilis. The partially purified TLA-1
-lactamase had a molecular mass of 31.4 kDa and a pI of 9.0 and
preferentially hydrolyzed cephaloridine, cefotaxime, cephalothin,
benzylpenicillin, and ceftazidime. The enzyme was markedly inhibited by
sulbactam, tazobactam, and clavulanic acid. TLA-1 is a new
extended-spectrum
-lactamase of Ambler class A.
*
Corresponding author. Mailing address: Departamento de
Resistencia Bacteriana, CISEI, Av. Universidad 655, Colonia Santa
María Ahuacatitlán, 62508, Cuernavaca, Morelos,
México. Phone: (52) 73-29-30-21. Fax: (52) 73-17-54-85. E-mail:
jsilva{at}insp3.insp.mx.
Present address: Instituo de Investigaciones Biomédicas.
Dpto. de Biotecnología. Circuito Escolar, Ciudad Universitaria, UNAM, México, D.F. C.P. 04510, Mexico.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |